Goal Fusion Wealth Management, LLC Recursion Pharmaceuticals, Inc. Transaction History

Goal Fusion Wealth Management, LLC

  • $180 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 24, 2022
SELL
$7.83 - $13.6 $31,320 - $54,400
-4,000 Reduced 16.67%
20,000 $213,000
Q2 2022

Jul 29, 2022
SELL
$5.04 - $9.26 $151,200 - $277,800
-30,000 Reduced 55.56%
24,000 $195,000
Q1 2022

May 06, 2022
BUY
$6.16 - $18.03 $332,640 - $973,620
54,000 New
54,000 $387,000

Others Institutions Holding RXRX

# of Institutions
286
Shares Held
242M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.12B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Goal Fusion Wealth Management, LLC Portfolio

Follow Goal Fusion Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goal Fusion Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Goal Fusion Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email